The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
CARMELL CORPORATION COM 142922103   392,662 103,061 SH   SOLE   103,061 0 0
DUOLINGO INC CL A COM 26603R106   82,190,931 362,314 SH   SOLE   362,314 0 0
NEUBASE THERAPEUTICS INC COM NEW 64132K201   34,762 46,970 SH   SOLE   46,970 0 0
PREDICTIVE ONCOLOGY INC COM 74039M309   34,078 10,358 SH   SOLE   10,358 0 0
VERA THERAPEUTICS INC CL A 92337R101   247,003 16,060 SH   SOLE   16,060 0 0
INNSUITES HOSPITALITY TRUST SH BEN INT 457919108   16,900 10,000 SH   SOLE   10,000 0 0